Titlebook: Lung Disease in Rheumatoid Arthritis; Aryeh Fischer,Joyce S. Lee Book 2018 Springer International Publishing AG 2018 Pulmonology.Rheumatol

保留

Rheumatoid Arthritis Pathogenesis and Pathophysiology,tiopathogenesis in each individual patient is likely slightly different. In this chapter we will discuss risk factors which contribute to the onset of RA as well as the cellular and humoral mediators which contribute to the pathology observed in both the articular and extra-articular manifestations of RA.

形狀

詳細目錄

婚姻生活

Management of the Rheumatoid Arthritis Patient with Interstitial Lung Disease, safety of non-biologic disease-modifying antirheumatic drugs (nbDMARDs), biologic DMARDs, biosimilars and targeted synthetic DMARDs in RA-ILD. In addition, the potential role for additional immunosuppression in RA-ILD is reviewed as well as overarching recommendations proposed for patient assessment to guide treatment decisions and management.

破譯密碼

The Non-ILD Pulmonary Manifestations of RA,pulmonary vasculitis. In addition, drug-induced lung disease and pulmonary infections are relatively common in this patient population. Appropriate management of pulmonary disease in patients with RA depends on identifying the exact nature of the pulmonary involvement and its severity as well as the underlying cause and individual patient context.

虛構的東西

9樓

cumber

10樓

外貌

10樓

Coronation

10樓

圓柱

10樓